SEP-363856 HCL (also known as Ulotaront; SEP363856; SEP-856 HCL), is a novel and potent orally bioactive trace amine-associated receptor 1 (TAAR1) agonist with serotonin 1A (5-HT1A) agonist activity.

Cyproheptadine HCl hydrate is a hydrochloride salt form of cyproheptadine which is a histamine receptor antagonist.

PRX-08066 is a potent and selective 5-HT2B receptor antagonist with IC50 of 3.4 nM, it prevents the severity of pulmonary arterial hypertension in the MCT rat model.

BRL 15572 free base is an antagonist of 5-HT1D with around 60× selectivity over other related receptors.

SB-242084 HCl, the hydrochloride salt of SB 242084, is a novel, potent and selective 5-HT2C receptor antagonist with pKi of 9.0 and with 158- and 100-fold selectivity over 5-HT2A and 5-HT2B receptors respectively.

Venlafaxine (Wy45030; Wy-45030; Effexor, Effexor XR, Lanvexin, Viepax and Trevilor), an approved and arylalkanolamine-based antidepressant, is an serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat various disorders including major depressive disorder (MDD), panic disorder and social phobia, generalised anxiety disorder (GAD).

Iloperidone (Fanapt, HP-873; HP 873; Zomaril), an atypical antipsychotic agent, is a potent antagonist of dopamine (D2)/serotonin (5-HT2) receptor which has been approved for the treatment of schizophrenia symptoms.

(R,R)-Palonosetron Hydrochloride is the active R,R-enantiomer of Palonosetron HCl (RS25259, RS-25259 197; trade name: Aloxi and Akynzeo) which is a 5-HT3 antagonist approved in 2018 in the prevention and treatment of chemotherapy-induced nausea and vomiting.

Dolasetron (MDL-73147) is a potent serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy.

Mosapride Citrate (formerly AS-4370; TAK-370 citrate; AS-4370 citrate; TAK 370 citrate) is a novel, potent and selective gastroprokinetic agent that has been used in patients with upper gastrointestinal disorders.